Study of Romiplostim for Chemotherapy Induced Thrombocytopenia
Clinical trial NCT02052882 · COMPLETED
Trial details
- NCT number
- NCT02052882
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-30
- Primary completion
- 2023-11-13
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.